Eledon Pharmaceuticals ELDN Stock
Eledon Pharmaceuticals Price Chart
Eledon Pharmaceuticals ELDN Financial and Trading Overview
| Eledon Pharmaceuticals stock price | 3.49 USD |
| Previous Close | 3.81 USD |
| Open | 3.79 USD |
| Bid | 2.7 USD x 200 |
| Ask | 4.68 USD x 200 |
| Day's Range | 3.61 - 3.81 USD |
| 52 Week Range | 1.35 - 4.6 USD |
| Volume | 897.07K USD |
| Avg. Volume | 1.46M USD |
| Market Cap | 290.23M USD |
| Beta (5Y Monthly) | 0.952 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.77 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 8.2 USD |
ELDN Valuation Measures
| Enterprise Value | 179.69M USD |
| Trailing P/E | N/A |
| Forward P/E | -5.1981807 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 2.8441753 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Eledon Pharmaceuticals Stock Price History
| Beta (5Y Monthly) | 0.952 |
| 52-Week Change | 24.50% |
| S&P500 52-Week Change | 27.69% |
| 52 Week High | 4.6 USD |
| 52 Week Low | 1.35 USD |
| 50-Day Moving Average | 3.49 USD |
| 200-Day Moving Average | 2.66 USD |
ELDN Share Statistics
| Avg. Volume (3 month) | 1.46M USD |
| Avg. Daily Volume (10-Days) | 935.52K USD |
| Shares Outstanding | 77.19M |
| Float | 69.93M |
| Short Ratio | 3.97 |
| % Held by Insiders | 1.09% |
| % Held by Institutions | 59.23% |
| Shares Short | 6.78M |
| Short % of Float | 8.79% |
| Short % of Shares Outstanding | 8.79% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:18 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -35.094% |
| Return on Equity (ttm) | -72.68% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -78147000 USD |
| Diluted EPS (ttm) | -0.77 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 111.09M USD |
| Total Cash Per Share (mrq) | 1.44 USD |
| Total Debt (mrq) | 555K USD |
| Total Debt/Equity (mrq) | 0.55 USD |
| Current Ratio (mrq) | 8.439 |
| Book Value Per Share (mrq) | 1.322 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -68893000 USD |
| Levered Free Cash Flow (ttm) | -39672500 USD |
Profile of Eledon Pharmaceuticals
| Country | United States |
| State | CA |
| City | Irvine |
| Address | 19800 MacArthur Boulevard |
| ZIP | 92612 |
| Phone | 949 238 8090 |
| Website | https://eledon.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 33 |
Eledon Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. It uses its immunology expertise in targeting the CD40 Ligand (CD40L) pathway to develop therapies to protect transplanted organs and prevent rejection, and to treat amyotrophic lateral sclerosis (ALS). The company's lead compound in development is tegoprubart, an IgG1 and anti-CD40L antibody with high affinity for CD40 Ligand, a biological target with therapeutic potential. It is also developing its products for the prevention of allograft rejection in kidney transplantation and xenotransplantation. The company has a collaboration agreement with eGenesis, Inc.; and a strategic collaboration with NewcelX Ltd. for the development of the NCEL-101 therapy for Type 1 Diabetes. The company was formerly known as Novus Therapeutics, Inc. and changed its name to Eledon Pharmaceuticals, Inc. in January 2021. Eledon Pharmaceuticals, Inc. is headquartered in Irvine, California.
Q&A For Eledon Pharmaceuticals Stock
What is a current ELDN stock price?
Eledon Pharmaceuticals ELDN stock price today per share is 3.49 USD.
How to purchase Eledon Pharmaceuticals stock?
You can buy ELDN shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Eledon Pharmaceuticals?
The stock symbol or ticker of Eledon Pharmaceuticals is ELDN.
Which industry does the Eledon Pharmaceuticals company belong to?
The Eledon Pharmaceuticals industry is Biotechnology.
How many shares does Eledon Pharmaceuticals have in circulation?
The max supply of Eledon Pharmaceuticals shares is 77.19M.
What is Eledon Pharmaceuticals Price to Earnings Ratio (PE Ratio)?
Eledon Pharmaceuticals PE Ratio is now.
What was Eledon Pharmaceuticals earnings per share over the trailing 12 months (TTM)?
Eledon Pharmaceuticals EPS is -0.77 USD over the trailing 12 months.
Which sector does the Eledon Pharmaceuticals company belong to?
The Eledon Pharmaceuticals sector is Healthcare.
Eledon Pharmaceuticals ELDN included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| US Tech Composite IXIC | 26853.98 USD — |
-0.89
|
8.32B USD — | 26769.16 USD — | 27130.88 USD — | — - | 8.32B USD — |
| US Tech Health Care IXHC | 1133.51 USD — |
+1.54
|
— — | 1113.35 USD — | 1133.95 USD — | — - | — — |
- {{ link.label }} {{link}}